KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with -$30000.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Change in Acquisitions & Divestments fell 129.13% year-over-year to -$30000.0, compared with a TTM value of $131000.0 through Dec 2023, changed N/A, and an annual FY2025 reading of $25.9 million, changed N/A over the prior year.
  • Change in Acquisitions & Divestments was -$30000.0 for Q2 2022 at Ginkgo Bioworks Holdings, down from $58000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $103000.0 in Q2 2021 and bottomed at -$30000.0 in Q2 2022.